Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The vaccine, based on an individual’s own tumor cells, improved survival time and proved safe in an early-stage trial.
Join us Sunday, April 28, 2019, to raise money, awareness, and connectedness with and for the National Brain Tumor Society!
Adam Hayden is a 36-year-old philosopher, advocate and writer who lives in Indianapolis with his wife and three sons.
A new breed of patient advocate is reshaping the future of cancer research.
I recognize that I feel powerless. Without claiming too much, I imagine my spouse to feel powerless, too.
“More of these studies are needed to make progress in…precision, or personalized, medicine,” said NCI’s Konstantin Salnikow, PhD.
During treatments, Tim Reagan says it was hard to get up each day to walk his dog, Brady. But getting up and out was exactly what he needed.
I’ve raised before the issue of talking to kids about cancer, but we face a combination of factors that affects our kids in untold ways.
Financial toxicity is also about the systemic designs of our assistance programs, which are not equipped to meet the needs of the very ill.
New target identified in glioblastoma could be effective against a common immortality mechanism in one third of cancers.
We are a community; how might we all learn together from our shared yet unique experiences?
Clinical trial tests personalized treatments in push to improve pediatric cancer survival.
The Republican lawmaker was diagnosed with glioblastoma, an aggressive brain cancer, last year.
In our brain-tumor community, each of us spend countless hours wondering what we will do when we receive news of a “bad scan.”
David Reardon, MD, and Patrick Y. Wen, MD, of Dana-Farber Cancer Institute talk targeted therapies and immunotherapy.
NExT combines the best of the federal government and the private sector, and it is only getting better with time.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.